These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25686590)

  • 1. Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.
    Zhang B; Chen K; Wang N; Gao C; Sun Q; Li L; Chen Y; Tan C; Liu H; Jiang Y
    Eur J Med Chem; 2015 Mar; 93():214-26. PubMed ID: 25686590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and potent antileukemic activities of 10-benzyl-9(10H)-acridinones.
    Gao C; Jiang Y; Tan C; Zu X; Liu H; Cao D
    Bioorg Med Chem; 2008 Sep; 16(18):8670-5. PubMed ID: 18713666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
    Murahari M; Prakash KV; Peters GJ; Mayur YC
    Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel multi-substituted benzyl acridone derivatives as survivin inhibitors for hepatocellular carcinoma treatment.
    Zhang B; Wang N; Zhang C; Gao C; Zhang W; Chen K; Wu W; Chen Y; Tan C; Liu F; Jiang Y
    Eur J Med Chem; 2017 Mar; 129():337-348. PubMed ID: 28237663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase.
    Babu YR; Bhagavanraju M; Reddy GD; Peters GJ; Prasad VV
    Arch Pharm (Weinheim); 2014 Sep; 347(9):624-34. PubMed ID: 24866341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological research of novel azaacridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.
    Li D; Yuan Z; Chen S; Zhang C; Song L; Gao C; Chen Y; Tan C; Jiang Y
    Bioorg Med Chem; 2017 Jul; 25(13):3437-3446. PubMed ID: 28511910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
    Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
    Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural optimizations and bioevaluation of N-substituted acridone derivatives as strong topoisomerase II inhibitors.
    Li ZY; Xu GS; Song YL; Li X
    Bioorg Chem; 2022 Feb; 119():105543. PubMed ID: 34929515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.
    Peng CK; Zeng T; Xu XJ; Chang YQ; Hou W; Lu K; Lin H; Sun PH; Lin J; Chen WM
    Eur J Med Chem; 2017 Feb; 127():187-199. PubMed ID: 28063351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
    Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
    Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of novel acridone derivatives as antiproliferative agents.
    Chen JN; Wu XK; Lu CH; Li X
    Bioorg Med Chem; 2021 Jan; 29():115868. PubMed ID: 33191085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
    Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents.
    Lang X; Li L; Chen Y; Sun Q; Wu Q; Liu F; Tan C; Liu H; Gao C; Jiang Y
    Bioorg Med Chem; 2013 Jul; 21(14):4170-7. PubMed ID: 23735826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
    Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
    Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.
    Lafayette EA; de Almeida SMV; Cavalcanti Santos RV; de Oliveira JF; Amorim CADC; da Silva RMF; Pitta MGDR; Pitta IDR; de Moura RO; de Carvalho Júnior LB; de Melo Rêgo MJB; de Lima MDCA
    Eur J Med Chem; 2017 Aug; 136():511-522. PubMed ID: 28531811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.
    Lee CC; Chang DM; Huang KF; Chen CL; Chen TC; Lo Y; Guh JH; Huang HS
    Bioorg Med Chem; 2013 Nov; 21(22):7125-33. PubMed ID: 24094433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.
    Zhang C; Li S; Ji L; Liu S; Li Z; Li S; Meng X
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4693-6. PubMed ID: 26384290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation and virtual screening of some acridone derivatives as potential anticancer agents.
    Oyedele AS; Bogan DN; Okoro CO
    Bioorg Med Chem; 2020 May; 28(9):115426. PubMed ID: 32201193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.
    Zhang C; Qu Y; Niu B
    Bioorg Med Chem; 2016 Nov; 24(22):5781-5786. PubMed ID: 27667553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies.
    Singla P; Luxami V; Singh R; Tandon V; Paul K
    Eur J Med Chem; 2017 Jan; 126():24-35. PubMed ID: 27744184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.